HighVolumeHDF as standard.
Fluid management for hemodialysis
Advanced fluid management for effective cardioprotection
The BCM - Body Composition Monitor was specifically designed to determine the amount of fluid overload that arises in patients suffering from renal failure. As a result, the BCM - Body Composition Monitor may help the clinician to determine a patient’s individual dry weight more accurately and, as a result, to remove the correct amount of fluid.
The BCM-Body Composition Monitor is the core component of Fresnenius Medical Care's Advanced Fluid Management therapy programme. It measures and quantifies the patient’s fluid status and provides a reliable decision basis for effective fluid and nutritional management. The BCM-Body Composition Monitor is a basic part of the CorDiax product line.
Cost-saving potential of fluid management
In dialysis patients, fluid overload is associated with acute complications, including congestive heart failure and pulmonary oedema. Fluid overload can require emergency dialysis outside of the routine dialysis sessions. These additional treatments are common and expensive.
BCM-Body Composition Monitor
From technology to therapy
Body weight and BMI (Body Mass Index) do not differentiate between muscle, fat and water. In addition, body composition is often described in terms of Fat Free Mass (FFM) and fat mass (fat) only, not considering overhydration.
The BCM–Body Composition Monitor is the first device on the market to distinguish the muscle mass from pathologic fluid overload. The BCM-Body Composition Monitor separates excess fluid (overhydration) from the lean and adipose tissue components of the body on the basis of a unique body composition model.
BCM — Body Composition Monitor
The three compartments
If you would like to order this product via the NHS Supply Chain Catalogue, please visit the following link: NHS Supply Chain Online Catalogue
Additional information relating to multiBic or Calrecia can be found in the critical care section of our product information page.
Adverse Events Reporting
Adverse events should be reported. Reporting forms and information can be found at
https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple app store. Adverse events should also be reported to Fresenius Medical Care on 01623 445100.
UK/HEMA/FME/0922/0005 Date of Preparation: November 2022
Related content
-
-
Proven Fresenius quality for standard hemodialysis.
No Results Found
1 Wizemann V. et al., Nephrology Dialysis Transplantation (2009); 24: 1574-1579.
2 Machek P. et al., Nephrology Dialysis Transplantation (2010); 25: 538-544.
3 Arneson T. et al., Clinical Journal of the American Society of Nephrology (2010); 5: 1054-1063.
4 Arneson T. et al., Clinical Journal of the American Society of Nephrology (2010); 5: 1054-1063.